Factors predicting long-term outcome and the need for surgery in Graves Orbitopathy: extended follow-up from the CIRTED Trial.
Peter N TaylorRathie RajendramStephanie HannaVictoria WilsonJulie PellChunhei LiAnne CookRao GattamaneniNicholas PlowmanSue JacksonRobert HillsRobert FrenchJimmy M UddinRichard Wj LeeColin M DayanPublished in: The Journal of clinical endocrinology and metabolism (2023)
In this long-term follow-up from a clinical trial, 3 year outcomes remained suboptimal with ongoing poor quality of life and high numbers requiring surgery. Importantly, reduction in CAS in the first year, a commonly used surrogate outcome measure, was not associated with improved long-term outcomes.